If You Invested in Turning Point Therapeutics (TPTX)
Looking for the current price? See the TPTX quote & overviewWhat $1,000 or $10,000 in TPTX Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Apr 17, 2019 |
|---|---|---|---|---|
| $1,000 | — | $1,716 +72% | — | $2,630 +163% |
| $10,000 | — | $17,162 +72% | — | $26,301 +163% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-08-16. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for TPTX$1,000 Investment Over Time
TPTX vs S&P 500Year-by-Year Returns
TPTX annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2019 | $28.90 | $62.29 | +115.5% | +115.5% |
| 2020 | $62.29 | $121.85 | +95.6% | +321.6% |
| 2021 | $121.85 | $47.70 | -60.9% | +65.1% |
| 2022 | $47.70 | $76.01 | +59.4% | +163.0% |
About Turning Point Therapeutics
NASDAQ
Frequently Asked Questions
Turning Point Therapeutics investment returns
How much would $1,000 invested in Turning Point Therapeutics be worth today?
If you invested $1,000 in Turning Point Therapeutics (TPTX) 5 years ago on 2021-11-01, your investment would be worth $1,716 as of 2022-08-16, a +71.6% price return without dividends, growing at a compounded rate of 98.4% per year (CAGR).
Has Turning Point Therapeutics outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare TPTX performance over available time periods.
What is Turning Point Therapeutics's average annual return?
The compound annual growth rate (CAGR) of TPTX’s share price over the past 5 years is 98.4%, without dividends. Individual years vary a great deal, and TPTX’s best recent full year was 2020 (+95.6%) while the worst was 2021 (-60.9%).
For informational and educational purposes only, not investment advice.
